Benefits
GLP-1 (semaglutide) therapy is commonly used to support:
Appetite regulation and reduced hunger signals
Decreased food cravings and improved portion control
Weight management through metabolic support
Improved insulin sensitivity and blood sugar regulation
Greater consistency with nutrition and lifestyle habits
Individual responses vary, and outcomes depend on personal health factors and treatment adherence.
How it Works
GLP-1 (semaglutide) works by mimicking a naturally occurring hormone involved in appetite regulation and metabolic signaling. Its mechanisms of action include:
Slowing gastric emptying to promote earlier and longer-lasting feelings of fullness after meals
Supporting appetite control between meals
Influencing insulin and glucose regulation by supporting the body’s insulin response
Reducing excess glucose production in the liver
Together, these effects help support metabolic function and weight management efforts over time. Treatment protocols, dosing, and progression are determined through medical intake and clinician review to ensure appropriate use and oversight.
What's Included
Each peptide program is provided under medical guidance and may include:
Prescription peptide medication delivered on a scheduled basis
Clinically appropriate supplementation when indicated
Nutrition guidance, including meal planning resources
On-demand fitness and movement support programs
Ongoing medical consultation and clinical oversight
Automated reminders and access to text-based support
Program components, delivery frequency, and included services may vary based on individual eligibility and medical review.
Side Effects & Considerations
As with many prescription therapies, GLP-1 (semaglutide) may cause side effects in some individuals.
The most commonly reported side effects include:
Nausea
Vomiting
Diarrhea
Constipation
Abdominal discomfort
These effects are typically mild to moderate and often improve over time as the body adjusts to treatment.
Less commonly, some individuals may experience:
Low blood sugar, particularly when used with other glucose-lowering medications
Changes in kidney function
Allergic reactions
GLP-1 therapy may not be appropriate for everyone and should be used with caution in individuals with certain underlying health conditions. A medical intake and clinician review are required to determine suitability.
Important Medical Warnings
GLP-1 (semaglutide) therapy is not appropriate for everyone and may be contraindicated in certain situations. These medications should not be used by individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome Type 2 (MEN 2).
Individuals with a history of pancreatitis should consult with a healthcare provider prior to starting GLP-1 therapy, as use of these medications may increase the risk of recurrence.
GLP-1 medications are not insulin and should not be used by individuals with type 1 diabetes or diabetic ketoacidosis.
There is limited data regarding the use of GLP-1 medications during pregnancy. As a result, GLP-1 therapy should not be used during pregnancy, should be discontinued if pregnancy occurs, and should be stopped in individuals planning to become pregnant.
Eligibility for GLP-1 therapy is determined through medical intake and clinician review based on individual health history and risk factors.
This page is informational. Medical decisions happen elsewhere.
Follow Us
© 2026 OasisPlus Therapies. All rights reserved.
Designed & built by Aegis Marketing